Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
RQM+ Launches Fern.ai
RQM+, the world’s leading MedTech service provider, today announced the launch of Fern.ai, the first […]
Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions
Thales, a global leader in software monetization and licensing, is collaborating with Lunit, a global […]
Lantern Pharma Receives FDA Clearance of IND Application for Drug Candidate LP-184 in Solid Tumors
Lantern Pharma, an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary […]
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Exai Bio today announced new data from a 3,300 subject study demonstrating that its novel […]
BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics
BPGbio, a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced […]
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Ultromics Granted FDA Breakthrough Device Designation for AI-Enhanced Cardiac Amyloidosis Detection
Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been […]
Landmark Study Finds Pison AI Technology Can Detect Neurological Disorder in ALS Patients
Pison, the pioneers behind AI-powered neural biosensors for health, wellness, and 3D touchless smart device […]
Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
Science and technology company Merck and XtalPi, a pioneering pharmaceutical technology company powered by artificial […]
Notable launches Patient AI, the world's first use of large language models and GPT to bring personalization at scale to healthcare
Notable, the leading intelligent automation company for healthcare, launched Patient AI, the world’s first use […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more